Predicting non‐response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities
Developmental Medicine & Child Neurology · 2024
DOI: 10.1111/dmcn.15837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2024. Verfasst von Lynn B Orriëns und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Neurology, Division of Paediatrics, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour,…. Hauptthemen laut MEDLINE: Sialorrhea, Botulinum Toxins, Type A, Neurodevelopmental Disorders, Submandibular Gland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To develop robust multivariable prediction models for non‐response to (1) submandibular botulinum neurotoxin A (BoNT‐A) injections and (2) concurrent submandibular and parotid (four‐gland) injections, to guide treatment decisions for drooling in children with neurodevelopmental disabilities, including cerebral palsy.
Method
This was a retrospective cohort study including 262 children (155 males/107 females, median age 7 years 11 months [IQR 5 years 1 month], range 4 years 0 months – 17 years 11 months) receiving submandibular injections and 74 children (52 males/22 females, median age 7 years 7 months [IQR 4 years 3 months], range 4 years 9 months – 18 years 8 months) receiving four‐gland injections. Multivariable logistic regression analyses were used to estimate associations between candidate predictors and non‐response 8 weeks after injection.
Results
Ninety‐six children (37%) were non‐responders to submandibular injections, for which developmental age was the strongest predictor (adjusted odds ratio [aOR] 2.13; 95% confidence interval [CI] 1.02–4.45 for developmental age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Neurology, Division of Paediatrics, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital, Nijmegen, the Netherlands.
- Department of Rehabilitation, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital, Nijmegen, the Netherlands.
- Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
ORCID-Profile: Lynn B Orriëns, Karen van Hulst, Michèl A A P Willemsen, Frank J A van den Hoogen
Zitieren
APA
Orriëns, L. B., van Hulst, K., Willemsen, M. A. A. P., van den Hoogen, F. J. A., & Erasmus, C. E. (2024). Predicting non‐response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15837
Vancouver
Orriëns LB, van Hulst K, Willemsen MAAP, van den Hoogen FJA, Erasmus CE. Predicting non‐response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities. Developmental Medicine & Child Neurology. 2024. doi:10.1111/dmcn.15837
BibTeX
@article{Orrins2024,
author = {Orriëns, Lynn B and van Hulst, Karen and Willemsen, Michèl A A P and van den Hoogen, Frank J A and Erasmus, Corrie E},
title = {Predicting non‐response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities},
journal = {Developmental Medicine & Child Neurology},
year = {2024},
doi = {10.1111/dmcn.15837}
}
EUVIMED